Blue Trust Inc’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27K | Sell |
239
-14,128
| -98% | -$75K | ﹤0.01% | 2207 |
|
|
2025
Q1 | $127K | Buy |
14,367
+5,214
| +57% | +$46.2K | ﹤0.01% | 892 |
|
|
2024
Q4 | $125K | Sell |
9,153
-3,510
| -28% | -$48.1K | ﹤0.01% | 843 |
|
|
2024
Q3 | $310K | Buy |
12,663
+1,404
| +12% | +$34.3K | ﹤0.01% | 658 |
|
|
2024
Q2 | $240K | Buy |
11,259
+2,365
| +27% | +$50.4K | ﹤0.01% | 641 |
|
|
2024
Q1 | $190K | Buy |
8,894
+2,165
| +32% | +$46.2K | ﹤0.01% | 525 |
|
|
2023
Q4 | $109K | Buy |
6,729
+1,186
| +21% | +$19.2K | ﹤0.01% | 649 |
|
|
2023
Q3 | $128K | Buy |
5,543
+4,431
| +398% | +$102K | ﹤0.01% | 552 |
|
|
2023
Q2 | $26K | Sell |
1,112
-10,266
| -90% | -$240K | ﹤0.01% | 950 |
|
|
2023
Q1 | $165K | Buy |
11,378
+2,350
| +26% | +$34.1K | ﹤0.01% | 607 |
|
|
2022
Q4 | $172K | Buy |
9,028
+4,589
| +103% | +$87.4K | ﹤0.01% | 504 |
|
|
2022
Q3 | $81K | Buy |
4,439
+775
| +21% | +$14.1K | ﹤0.01% | 604 |
|
|
2022
Q2 | $92K | Buy |
+3,664
| New | +$92K | ﹤0.01% | 519 |
|